pemetrexed,cisplatin,gemcitabine,pembrolizumab,carboplatin,venetoclax,vinflunine,nivolumab,docetaxel,cemiplimab,anbenitamab,cetuximab,acalabrutinib,int230-6,tisotumab vedotin,ipilimumab,erfonrilimab,favezelimab,paclitaxel,bms-986218,vibostolimab,niraparib,io-108,rituximab,bendamustine
merck,eli lilly,astrazeneca,seagen,bms,pierre fabre,roche,gsk,intensity therapeutics,regeneron,elphamab,genmab,immune-onc therapeutics,abbvie
['keynote,671', 'lung', 'keynote 671', 'pembro']
keynote 671 results published today at and presented at #asco23 adds pembrolizumab as a new player for neoadjuvant chemoimmunotherapy in resectable lung cancer 
Born in Majorca. Medical oncologist. Clinical researcher. Focused in lung cancer. World citizen. Major concerns: human inequality and blue planet environment